On Air Now

Current Show

Early Morning Journal   5:30 AM - 6:00 AM

The latest information to get your morning going on the Early Morning Journal

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

1590 AM Coldwater, Michigan 95.5 FM Coldwater, Michigan

Weather

Current Conditions(Coldwater,MI 49036)

More Weather »
47° Feels Like: 42°
Wind: WSW 9 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Rain 59°

Tonight

Mostly Clear 43°

Tomorrow

Mostly Sunny 60°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

FDA advisory panel rejects J&J drug for acute coronary syndrome

(Reuters) - Johnson & Johnson's anticoagulant Xarelto should not be approved to prevent further heart problems in patients who have recently suffered a heart attack, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.

The panel voted 10 to 0, with one abstention, against approval, saying data from a single clinical trial was not strong enough to justify approval, especially since some data from the trial was missing.

Xarelto is already used to treat and prevent deep vein thrombosis and pulmonary embolisms and to reduce the risk of stroke and blood clots in patients with an irregular heart beat that is not caused by heart problems.

(Reporting by Toni Clarke in Washington; Editing by Bernard Orr)

Comments